COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation

Vaccines offer a hope toward ending the global pandemic caused by SARS-CoV2. Mass vaccination of the global population offers hope to curb the spread. Developing nations, however, face monumental challenges in procurement, allocation, distribution and uptake of vaccines. Inequities in vaccine supply...

Full description

Bibliographic Details
Main Authors: Abu Baker Sheikh, Suman Pal, Nismat Javed, Rahul Shekhar
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Infectious Disease Reports
Subjects:
Online Access:https://www.mdpi.com/2036-7449/13/2/41
id doaj-6fcfb2df9ca347f292e4d47c46384466
record_format Article
spelling doaj-6fcfb2df9ca347f292e4d47c463844662021-06-01T00:05:44ZengMDPI AGInfectious Disease Reports2036-74492021-05-01134142943610.3390/idr13020041COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for InnovationAbu Baker Sheikh0Suman Pal1Nismat Javed2Rahul Shekhar3Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USADepartment of Internal Medicine, Division of Hospital Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131, USAShifa College of Medicine, Shifa Tameer-e-Millat University, Islamabad 44000, PakistanDepartment of Internal Medicine, Division of Hospital Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131, USAVaccines offer a hope toward ending the global pandemic caused by SARS-CoV2. Mass vaccination of the global population offers hope to curb the spread. Developing nations, however, face monumental challenges in procurement, allocation, distribution and uptake of vaccines. Inequities in vaccine supply are already evident with resource-rich nations having secured a large chunk of the available vaccine doses for 2021. Once supplies are made available, vaccines will have to be distributed and administered to entire populations—with considerations for individual risk level, remote geography, cultural and socio-economic factors. This would require logistical and trained personnel support that can be hard to come by for resource-poor nations. Several vaccines also require ultra-cold temperatures for storage and transport and therefore the need for specialized equipment and reliable power supply which may also not be readily available. Lastly, attention will need to be paid to ensuring adequate uptake of vaccines since vaccine hesitancy has already been reported for COVID vaccines. However, existing strengths of local and regional communities can be leveraged to provide innovative solutions and mitigate some of the challenges. Regional and international cooperation can also play a big role in ensuring equity in vaccine access and vaccination.https://www.mdpi.com/2036-7449/13/2/41vaccine equityhesitancyCOVAXdeveloping countries
collection DOAJ
language English
format Article
sources DOAJ
author Abu Baker Sheikh
Suman Pal
Nismat Javed
Rahul Shekhar
spellingShingle Abu Baker Sheikh
Suman Pal
Nismat Javed
Rahul Shekhar
COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation
Infectious Disease Reports
vaccine equity
hesitancy
COVAX
developing countries
author_facet Abu Baker Sheikh
Suman Pal
Nismat Javed
Rahul Shekhar
author_sort Abu Baker Sheikh
title COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation
title_short COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation
title_full COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation
title_fullStr COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation
title_full_unstemmed COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation
title_sort covid-19 vaccination in developing nations: challenges and opportunities for innovation
publisher MDPI AG
series Infectious Disease Reports
issn 2036-7449
publishDate 2021-05-01
description Vaccines offer a hope toward ending the global pandemic caused by SARS-CoV2. Mass vaccination of the global population offers hope to curb the spread. Developing nations, however, face monumental challenges in procurement, allocation, distribution and uptake of vaccines. Inequities in vaccine supply are already evident with resource-rich nations having secured a large chunk of the available vaccine doses for 2021. Once supplies are made available, vaccines will have to be distributed and administered to entire populations—with considerations for individual risk level, remote geography, cultural and socio-economic factors. This would require logistical and trained personnel support that can be hard to come by for resource-poor nations. Several vaccines also require ultra-cold temperatures for storage and transport and therefore the need for specialized equipment and reliable power supply which may also not be readily available. Lastly, attention will need to be paid to ensuring adequate uptake of vaccines since vaccine hesitancy has already been reported for COVID vaccines. However, existing strengths of local and regional communities can be leveraged to provide innovative solutions and mitigate some of the challenges. Regional and international cooperation can also play a big role in ensuring equity in vaccine access and vaccination.
topic vaccine equity
hesitancy
COVAX
developing countries
url https://www.mdpi.com/2036-7449/13/2/41
work_keys_str_mv AT abubakersheikh covid19vaccinationindevelopingnationschallengesandopportunitiesforinnovation
AT sumanpal covid19vaccinationindevelopingnationschallengesandopportunitiesforinnovation
AT nismatjaved covid19vaccinationindevelopingnationschallengesandopportunitiesforinnovation
AT rahulshekhar covid19vaccinationindevelopingnationschallengesandopportunitiesforinnovation
_version_ 1721415779927195648